Inizio announced Wednesday morning that it is acquiring Evolution Road, a digital innovation company.
As part of the deal, Evolution Road will become part of Evoke, a 2022 MM+M Agency 100 honoree and the marcomms business unit of Inizio. Inizio said that Evolution Road will boost Evoke’s “commercial innovation offering, digital health solutions, and end-to-end omnichannel suite of services.”
According to MM+M’s Agency 100 report, Evoke generated $304.4 million in revenue last year and grew 15% year-over-year.
In a statement, Evoke CEO Reid Connolly welcomed Evolution Road to the company
“There is a high level of demand from nearly all life science organizations to not merely provide strategic counsel but to help bring their omnichannel capability to life at every aspect of the journey,” Connolly said. “The combination of Evolution Road’s expertise, alongside Evoke’s data, customer experience and media teams will underscore Evoke’s reputation as one of the most comprehensive, forward-looking and indispensable omnichannel partners in the market.”
Evolution Road President Larry Moran said the transaction will result in the “most powerful” omnichannel offering in the healthcare space, while Evolution Road CEO Paul Ivans commended Inizio for having a shared culture and set of values.
2022 has been a year of new beginnings for Inizio and its respective properties.
In June, Inizio was created by the merger of Huntsworth and Ashfield, establishing a $1.5 billion company comprising five specialist business units and more than 10,000 employees across 35 countries.
Meanwhile, Evoke acquired life sciences agency Meltmedia, which now operates as Evoke Melt. Additionally, Evoke North America appointed five veteran executives over the summer to oversee operations at three offices in the U.S.
The Evolution Road deal was announced the same day as CrowdPharm’s acquisition of Boom Ideanet, an advertising agency based in Kansas City, as part of a move designed to bolster its integrated consumer offerings.
Details of the acquisition were not made public.
“With this acquisition, CrowdPharm gains even more established knowledge in building network communities as well as years of experience in consumer advertising,” CrowdPharma co-founder and partner Steve Bernstein said in a statement.
